University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7030, USA.
Clin Infect Dis. 2010 May 15;50 Suppl 3(0 3):S85-95. doi: 10.1086/651478.
Antiretroviral therapy (ART) has the potential to prevent human immunodeficiency virus (HIV) transmission by reducing the concentration of HIV in blood and genital secretions. Indeed, mathematical models with favorable assumptions suggest the potential of ART to stop the spread of HIV infection. Empirical results from ecological and population-based studies and from several short-term observational studies involving HIV status-discordant heterosexual couples suggest that ART reduces the rate of HIV transmission. A multinational, randomized, controlled trial (National Institutes of Health HPTN052) examining the reliability and durability of ART as prevention of transmission in HIV status-discordant couples is under way. The latter and other studies also consider sexual risk-taking behavior and transmission of HIV-resistant variants when ART is used as prevention. Early HIV detection and treatment (ie, test and treat) are being considered as an important prevention strategy. In this article, we review the data supporting the use of ART to prevent HIV transmission and critically examine the public health implications of this strategy.
抗逆转录病毒疗法(ART)通过降低血液和生殖分泌物中 HIV 的浓度,具有预防人类免疫缺陷病毒(HIV)传播的潜力。事实上,带有有利假设的数学模型表明,ART 有可能阻止 HIV 感染的传播。来自生态学和基于人群的研究以及涉及 HIV 状态不一致的异性恋夫妇的几项短期观察性研究的实证结果表明,ART 降低了 HIV 传播的速度。一项正在进行的多国、随机、对照试验(美国国立卫生研究院 HPTN052)正在研究 ART 作为 HIV 状态不一致的夫妇传播预防的可靠性和持久性。后者和其他研究也考虑了在使用 ART 作为预防时的性行为风险行为和 HIV 耐药变体的传播。早期 HIV 检测和治疗(即检测和治疗)被认为是一种重要的预防策略。本文综述了支持使用 ART 预防 HIV 传播的数据,并批判性地审查了这一策略对公共卫生的影响。